Don Holzworth

Donald A. Holzworth was the Founder, Chairman, and Chief Executive Officer of Constella Group, a leading global provider of health consulting services dedicated to enhancing human health around the world, every day. In August 2007, Holzworth completed the sale of Constella to SRA International, Inc., a $1.5 billion technology services and consulting firm. Holzworth served as Senior Vice President and Director and was responsible for strategic development of SRA's new $300 million Global Health Sector. He now serves as a Strategic Consultant to the CEO.

From 1991 to 2007, Holzworth guided Constella's revenue growth to more than $200 million, increased the company's number of employees to more than 1,500, and the scope of the company's operations to 61 countries. In 2003 and again in 2007, the North Carolina Council for Entrepreneurial Development recognized Constella with its Entrepreneurial Excellence Award. In 2005, Ernst & Young named Holzworth as a Carolinas Entrepreneur of the Year® and he now serves as both a regional and national judge for this prestigious program.

Prior to Constella, Mr. Holzworth spent 9 years as a senior executive with another consulting firm, leading that company's life sciences business and growth from $6 million to $70 million in revenue before its sale in 1990. In 2002, Holzworth was a co-founder and served as the inaugural CEO of Expression Analysis, Inc., a start-up genomic services company spun out of Duke University Medical Center. He now serves as the company's Chairman of the Board. Holzworth also serves on the board of directors for the Accordia Global Health Foundation and the Campbell Alliance Group. He is an Adjunct Professor of Health Policy and Administration and a member of the University of North Carolina at Chapel Hill School of Public Health's Advisory Board and the University of North Carolina at Chapel Hill's Board of Visitors.